Research team
Expertise
My expertise encompasses a range of research activities in basic and translational research, aimed at developing effective new combination treatments for solid tumors through targeted and immune therapies, and by unraveling resistance mechanisms. Specifically, my focus is on head and neck cancers. Regarding targeted therapies, I have specialized in the anti-EGFR inhibitor cetuximab and PI3K/Akt pathway inhibitors. Additionally, I am conducting research on cell therapy using CAR-NK cells.